Under construction – not a live service
Sign in
Not yet taking people in GermanyPhase 1

Testing nurandociguat with sildenafil for high blood pressure in men

Tests how safe nurandociguat is with sildenafil in men with high blood pressure.

Key facts

Who runs it
Bayer AG
Where
Berlin and Mannheim, GermanySee the 2 sites
Registry title
A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension.
Status
Not yet recruiting
Phase
Phase 1
People taking part
36 people, planned
Started
1 Oct 2026
Expected to end
24 Dec 2026
Type of study
Interventional
Record updated
28 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for men aged 18 to 64 with arterial hypertension, to learn how safe nurandociguat is when taken with sildenafil.

Age
18 to 64 years
Sex
Men only

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Germany

  • CRS Clinical Research Services Berlin GmbHBerlin, GermanyNot yet recruiting
  • CRS Clinical Research Services Mannheim GmbHMannheim, GermanyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Testing nurandociguat with sildenafil for high blood pressure in menGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2025-522336-14-00, who can take part
Record updated
28 October 2026